Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanjie Quban Fang
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sanjie Quban Fang (散结祛瘢方) is a traditional Chinese medicine (TCM) formula developed for the treatment of keloids and hypertrophic scars. Its primary mechanism is believed to involve the inhibition of abnormal proliferation, migration, and secretory function of keloid fibroblasts, thereby suppressing persistent growth of keloid tissue[1][2]. The formula typically consists of multiple herbal ingredients with properties aimed at resolving masses ("san jie"), removing scars ("qu ban"), reducing inflammation, and modulating fibrotic processes. Clinical studies are ongoing to validate its efficacy in scar management[1][2].
- Brand names
- Sanjie Quban Formula
- Other names
- 散结祛瘢方
Beyond the preview
Go deeper on Sanjie Quban Fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanjie Quban Fang.